Jason Liu

Jason Liu is the Chief Executive Officer of WuXi Diagnostics, a platform company in China focusing on integrated diagnostics.1 He has led the company since its establishment in 2018, guiding it to several significant achievements, including:

1. Launching a strategic collaboration with Thermo Fisher and Mayo Clinic for COVID-19 detection.1
2. Creating innovative diagnostic solutions for biliary atresia and individualized precise medication.1
3. Building partnerships with pharmaceutical companies, health insurance groups, and other healthcare industry partners to create a precision medicine innovation ecosystem.1

Under Liu's leadership, WuXi Diagnostics secured a US$150 million Series B financing round in February 2021, which included investments from major companies like Thermo Fisher Scientific.1 This funding was aimed at strengthening the company's open-access innovation platform, advancing its integrated diagnostics R&D pipeline, and accelerating market penetration in the global diagnostics sector.1

Liu's professional background includes:

• Education: Pepperdine University, The George L. Graziadio School of Business and Management3
• Location: Minhang District3

It's worth noting that WuXi Diagnostics' joint venture with Mayo Clinic concluded in early February 2024.2